Professor of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, NC, United States
David van Duin, MD, PhD, FIDSA, FAST. Professor in the Infectious Diseases Division at the University of North Carolina. Dr. van Duin is the founding Director of the Immunocompromised Host ID service. His main research interests are infections caused by multi-drug resistant Gram-negative bacteria, especially carbapenem-resistant Enterobacterales, and infections in immunocompromised patients.
Disclosure(s): Merck: Advisor/Consultant (), Grant/Research Support (); Pfizer: Advisor/Consultant (); Qpex: Advisor/Consultant (); Roche: Advisor/Consultant (); Shionogi: Advisor/Consultant (), Grant/Research Support ()
Thursday, October 17, 2024
11:15 AM – 11:30 AM US PT
Friday, October 18, 2024
8:00 AM – 9:00 AM US PT
250 - Duration of treatment of Gram-negative bacteremia in immunocompromised patients
Friday, October 18, 2024
8:00 AM – 8:30 AM US PT
Friday, October 18, 2024
10:42 AM – 10:54 AM US PT
Friday, October 18, 2024
11:30 AM – 11:43 AM US PT